| 生物活性 | |||
|---|---|---|---|
| 描述 | Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT01802775 | Peripheral Arterial Disease | Phase 2 | Completed | - | - | 
| NCT01802775 | - | Completed | - | - | |
| NCT02047565 | Bleeding | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Quintiles Overland Park, Kansas, United States, 66211 收起 << | 
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 1.39mL 0.28mL 0.14mL | 6.94mL 1.39mL 0.69mL | 13.88mL 2.78mL 1.39mL | 
| 参考文献 | 
|---|